BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7404090)

  • 21. Control of pancreatic polypeptide secretion by glucose in man.
    Marco J; Hedo JA; Villanueva ML
    J Clin Endocrinol Metab; 1978 Jan; 46(1):140-5. PubMed ID: 752016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in glucagon kinetics and processing in patients with acute pancreatitis.
    Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Kinoshita K; Azuhata T
    Hepatogastroenterology; 2007 Jun; 54(76):1250-5. PubMed ID: 17629081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diurnal profile of plasma motilin concentrations during fasting and feeding in man.
    Funakoshi A; Ho LL; Jen KL; Knopf R; Vinik AI
    Gastroenterol Jpn; 1985 Oct; 20(5):446-56. PubMed ID: 3908210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Human pancreatic polypeptide (hPP)].
    Funakoshi A
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():666-9. PubMed ID: 8753329
    [No Abstract]   [Full Text] [Related]  

  • 25. Availability of plasma pancreatic polypeptide measurement in diagnosis of chronic pancreatitis.
    Yamamura T; Mori K; Tatsumi M; Kotoura Y; Yoshiya K; Itoh N; Seino Y
    Scand J Gastroenterol; 1981; 16(6):757-61. PubMed ID: 7323707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum immunoreactive trypsin, pancreatic polypeptide, and pancreatic isoamylase as diagnostic tests for chronic pancreatitis.
    Enslev L; Andersen BN; Fahrenkrug J; Magid E; Thorsgaard-Pedersen N
    Scand J Gastroenterol; 1984 Mar; 19(2):204-8. PubMed ID: 6719033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the pancreatic polypeptide response to hypoglycemia in man.
    Zulueta MA; Vincent E; Correas I; Villanueva ML; Felíu JE; Marco J
    Diabete Metab; 1982 Mar; 8(1):47-51. PubMed ID: 7047252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma cholecystokinin and pancreatic polypeptide responses after ingestion of a liquid test meal rich in medium-chain fatty acids in patients with chronic pancreatitis.
    Nakano I; Funakoshi A; Shinozaki H; Sakai K
    Am J Clin Nutr; 1989 Feb; 49(2):247-51. PubMed ID: 2916444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of human pancreatic polypeptide and gastrin by Boots and GIH secretin: in vitro and in vivo studies.
    Meryn S; Bauman WA; Panzer S; Straus E
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):1-6. PubMed ID: 3557722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between exocrine pancreatic function and plasma pancreatic polypeptide response to food in chronic pancreatitis.
    Ventrucci M; Pezzilli R; Bonsi P; Lezoche G; Gullo L; Barbara L
    Panminerva Med; 1988; 30(1):10-2. PubMed ID: 3419846
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic polypeptide response in patients with chronic pancreatitis.
    Valenzuela JE; Taylor IL; Walsh JH
    Dig Dis Sci; 1979 Nov; 24(11):862-4. PubMed ID: 520107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-four-hour variations of plasma pancreatic polypeptide, insulin and glucagon in normal human subjects.
    Tasaka Y; Inoue S; Maruno K; Hirata Y
    Endocrinol Jpn; 1980 Aug; 27(4):495-8. PubMed ID: 7007033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon treatment of experimental acute pancreatitis.
    Papp M; Ribet A; Fodor I; Németh PE; Fehér S; Horváth JE; Folly G
    Acta Med Acad Sci Hung; 1975; 32(2):105-16. PubMed ID: 1235217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin attenuates the development of acute pancreatitis in rat.
    Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
    J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic polypeptide (PP) responses to oral and intravenous glucose in man.
    Sive AA; Vinik AI; van Tonder SV
    Am J Gastroenterol; 1979 Feb; 71(2):183-5. PubMed ID: 433901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
    Okumura N; Hayakawa T; Yasui K; Noda A; Kondo T; Otsuka K; Nimura Y
    Gastroenterol Jpn; 1982; 17(4):347-52. PubMed ID: 7141199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.